Year-end Sale % OFF 
Abstract
Heart failure (HF) is a major public health problem characterized by inability of the heart to maintain sufficient output of blood. The systematic characterization of circulating proteins across different stages of HF may provide pathophysiological insights and identify therapeutic targets. Here we report application of aptamer-based proteomics to identify proteins associated with prospective HF incidence in a population-based cohort, implicating modulation of immunological, complement, coagulation, natriuretic and matrix remodeling pathways up to two decades prior to overt disease onset. We observe further divergence of these proteins from the general population in advanced HF, and regression after heart transplantation. By leveraging coronary sinus samples and transcriptomic tools, we describe likely cardiac and specific cellular origins for several of the proteins, including Nt-proBNP, thrombospondin-2, interleukin-18 receptor, gelsolin, and activated C5. Our findings provide a broad perspective on both cardiac and systemic factors associated with HF development.
Highlights
Heart failure (HF) is a major public health problem characterized by inability of the heart to maintain sufficient output of blood
Our results provide a comprehensive perspective on the plasma proteome in HF and identify both cardiac and extracardiac circulating proteins associated with HF incidence which display a graded increase across nonfailing, early HF and advanced HF populations
Our findings are consistent with activation of a number of pathways in early stages of HF, including immunological, complement, coagulation, natriuretic and extracellular matrix remodeling pathways, whereas pervasive perturbation of the plasma proteome was observed in manifest HF
Summary
Heart failure (HF) is a major public health problem characterized by inability of the heart to maintain sufficient output of blood. Circulating levels of angiotensin II, aldosterone, catecholamines and natriuretic peptides are all increased in heart failure, associated with increased mortality 4, and constitute the principal targets for HF therapy[1]. These targets were originally identified from candidate-based physiological studies. Our results provide a comprehensive perspective on the plasma proteome in HF and identify both cardiac and extracardiac circulating proteins associated with HF incidence which display a graded increase across nonfailing, early HF and advanced HF populations
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
